Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Conrad

Showing results (111-120 of 118) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 118 results.
American Journal of Human Genetics|April 16, 1998
Mutations in the EXT1 and EXT2 genes in hereditary multiple exostosesW Wuyts, W Van Hul, K De Boulle, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 9, 2011
PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel, and CMF versus a standard-dosed epirubicin-cyclophosphamide followed by paclitaxel with or without darbepoetin alfa in primary breast cancer--outcome on prognosisM Untch, G von Minckwitz, G E Konecny, et al.
Journal for Immunotherapy of Cancer|October 16, 2014
Tetramer guided, cell sorter assisted production of clinical grade autologous NY-ESO-1 specific CD8(+) T cellsSeth M Pollack, Robin L Jones, Erik A Farrar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 10, 2011
PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel and CMF versus a standard-dosed epirubicin/cyclophosphamide followed by paclitaxel ± darbepoetin alfa in primary breast cancer--results at the time of surgeryM Untch, P A Fasching, G E Konecny, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 11, 2014
Soft tissue sarcoma, version 2.2014Margaret von Mehren, R Lor Randall, Robert S Benjamin, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 11, 2016
Soft Tissue Sarcoma, Version 2.2016, NCCN Clinical Practice Guidelines in OncologyMargaret von Mehren, R Lor Randall, Robert S Benjamin, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 11, 2012
Soft tissue sarcoma, version 2.2012: featured updates to the NCCN guidelinesMargaret von Mehren, Robert S Benjamin, Marilyn M Bui, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 14, 2014
Gastrointestinal stromal tumors, version 2.2014Margaret von Mehren, R Lor Randall, Robert S Benjamin, et al.
Pageof 12

Showing results (111-120 of 118) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 118 results.
American Journal of Human Genetics|April 16, 1998
Mutations in the EXT1 and EXT2 genes in hereditary multiple exostosesW Wuyts, W Van Hul, K De Boulle, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 9, 2011
PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel, and CMF versus a standard-dosed epirubicin-cyclophosphamide followed by paclitaxel with or without darbepoetin alfa in primary breast cancer--outcome on prognosisM Untch, G von Minckwitz, G E Konecny, et al.
Journal for Immunotherapy of Cancer|October 16, 2014
Tetramer guided, cell sorter assisted production of clinical grade autologous NY-ESO-1 specific CD8(+) T cellsSeth M Pollack, Robin L Jones, Erik A Farrar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 10, 2011
PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel and CMF versus a standard-dosed epirubicin/cyclophosphamide followed by paclitaxel ± darbepoetin alfa in primary breast cancer--results at the time of surgeryM Untch, P A Fasching, G E Konecny, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 11, 2014
Soft tissue sarcoma, version 2.2014Margaret von Mehren, R Lor Randall, Robert S Benjamin, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 11, 2016
Soft Tissue Sarcoma, Version 2.2016, NCCN Clinical Practice Guidelines in OncologyMargaret von Mehren, R Lor Randall, Robert S Benjamin, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 11, 2012
Soft tissue sarcoma, version 2.2012: featured updates to the NCCN guidelinesMargaret von Mehren, Robert S Benjamin, Marilyn M Bui, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 14, 2014
Gastrointestinal stromal tumors, version 2.2014Margaret von Mehren, R Lor Randall, Robert S Benjamin, et al.
Pageof 12